Market Closed -
Hong Kong S.E.
04:08:28 2024-05-24 am EDT
|
5-day change
|
1st Jan Change
|
8.2
HKD
|
-2.15%
|
|
-8.48%
|
-37.12%
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
8,621
|
5,529
|
-
|
-
|
Enterprise Value (EV)
1 |
8,621
|
4,206
|
3,951
|
4,489
|
P/E ratio
|
38.2
x
|
15.3
x
|
10.7
x
|
10.5
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.61
x
|
1.55
x
|
1.24
x
|
1.07
x
|
EV / Revenue
|
2.61
x
|
1.18
x
|
0.88
x
|
0.87
x
|
EV / EBITDA
|
12.3
x
|
5.71
x
|
4.19
x
|
4.5
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
2.7
x
|
2.1
x
|
1.86
x
|
Nbr of stocks (in thousands)
|
727,355
|
727,355
|
-
|
-
|
Reference price
2 |
11.85
|
7.601
|
7.601
|
7.601
|
Announcement Date
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
3,298
|
3,567
|
4,474
|
5,150
|
EBITDA
1 |
-
|
701.9
|
736.2
|
941.8
|
997.3
|
EBIT
1 |
-
|
534.4
|
596.5
|
775.3
|
899.9
|
Operating Margin
|
-
|
16.21%
|
16.72%
|
17.33%
|
17.47%
|
Earnings before Tax (EBT)
1 |
-
|
349.4
|
504.2
|
785.5
|
787.9
|
Net income
1 |
680.8
|
234.9
|
375.3
|
549.3
|
528.2
|
Net margin
|
-
|
7.12%
|
10.52%
|
12.28%
|
10.26%
|
EPS
2 |
0.9600
|
0.3100
|
0.4977
|
0.7100
|
0.7229
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/19/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
1,323
|
1,578
|
1,040
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
20.7%
|
22.2%
|
20%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
6.9%
|
9.58%
|
8%
|
Assets
1 |
-
|
-
|
5,438
|
5,735
|
6,603
|
Book Value Per Share
2 |
-
|
-
|
2.810
|
3.620
|
4.100
|
Cash Flow per Share
2 |
-
|
-
|
0.5400
|
1.000
|
0.9300
|
Capex
1 |
-
|
-
|
322
|
410
|
379
|
Capex / Sales
|
-
|
-
|
9.03%
|
9.17%
|
7.37%
|
Announcement Date
|
6/19/23
|
3/28/24
|
-
|
-
|
-
|
Last Close Price
7.601
CNY Average target price
14.36
CNY Spread / Average Target +88.89% Consensus |
1st Jan change
|
Capi.
|
---|
| -37.12% | 763M | | -23.07% | 7.86B | | +1.88% | 2.63B | | -8.06% | 2.5B | | -41.95% | 2.33B | | -11.99% | 1.82B | | -21.18% | 1.51B | | +17.44% | 1.22B | | -43.89% | 1.14B | | +14.78% | 957M |
Medical & Diagnostic Laboratories
|